Elevated cholesterol precursors other than cholestanol can also be a hallmark for CTX
暂无分享,去创建一个
M. D. de Barse | R. Berger | A. Verrips | G. Visser | M. G. M. de Sain-van der Velden | B. Prinsen | M. D. S. D. Velden | Gepke Visser | Ruud Berger | M. M. J. D. Barse
[1] H. Isoniemi,et al. Sterol parameters as markers of liver function in primary biliary cirrhosis before and after liver transplantation , 2005, Transplant international : official journal of the European Society for Organ Transplantation.
[2] J. Carpten,et al. Fine-mapping, mutation analyses, and structural mapping of cerebrotendinous xanthomatosis in U.S. pedigrees. , 2001, Journal of lipid research.
[3] C. Maslen,et al. Mutation analysis and description of sixteen RSH/Smith-Lemli-Opitz syndrome patients: polymerase chain reaction-based assays to simplify genotyping. , 2000, American journal of medical genetics.
[4] F. Gabreëls,et al. Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. , 2000, Brain : a journal of neurology.
[5] F. Gabreëls,et al. Effect of simvastatin in addition to chenodeoxycholic acid in patients with cerebrotendinous xanthomatosis. , 1999, Metabolism: clinical and experimental.
[6] G. Watts,et al. Inhibition of cholesterogenesis decreases hepatic secretion of apoB-100 in normolipidemic subjects. , 1997, The American journal of physiology.
[7] H. Segev,et al. Premature termination codon at the sterol 27-hydroxylase gene causes cerebrotendinous xanthomatosis in a French family , 1995, Human Genetics.
[8] Y. Tokimura,et al. Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use , 1994, Journal of the Neurological Sciences.
[9] G. Tint,et al. Comparative effects of lovastatin and chenodeoxycholic acid on plasma cholestanol levels and abnormal bile acid metabolism in cerebrotendinous xanthomatosis. , 1994, Metabolism: clinical and experimental.
[10] Z. Meiner,et al. Cerebrotendinous xanthomatosis , 1994, Neurology.
[11] Y. Matsuzawa,et al. Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosis. , 1991, Metabolism: clinical and experimental.
[12] U. Francke,et al. Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. , 1991, The Journal of biological chemistry.
[13] J. C. van der Molen,et al. Use of determinations of 7-lathosterol (5 alpha-cholest-7-en-3 beta-ol) and other cholesterol precursors in serum in the study and treatment of disturbances of sterol metabolism, particularly cerebrotendinous xanthomatosis. , 1991, Journal of lipid research.
[14] M. Osame,et al. High levels of plant sterols and cholesterol precursors in cerebrotendinous xanthomatosis. , 1991, Journal of lipid research.
[15] B. Kottke,et al. Effect of 25-hydroxycholesterol and bile acids on the regulation of cholesterol metabolism in Hep G2 cells. , 1989, The Biochemical journal.
[16] A. Quyyumi,et al. Aneurysmal coronary artery disease in cerebrotendinous xanthomatosis. , 1988, The American journal of cardiology.
[17] G. Tint,et al. Biosynthesis of bile acids in cerebrotendinous xanthomatosis. Relationship of bile acid pool sizes and synthesis rates to hydroxylations at C-12, C-25, and C-26. , 1985, The Journal of clinical investigation.
[18] A. Batta,et al. Effect of chenodeoxycholic acid on biliary and urinary bile acids and bile alcohols in cerebrotendinous xanthomatosis; monitoring by high performance liquid chromatography. , 1985, Journal of lipid research.
[19] S. Shefer,et al. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. , 1984, The New England journal of medicine.
[20] M. Une,et al. Occurrence of bile alcohol glucuronides in bile of patients with cerebrotendinous xanthomatosis. , 1980, Journal of lipid research.
[21] S. Shefer,et al. Bile alcohol metabolism in man. Conversion of 5beta-cholestane-3alpha, 7alpha,12alpha, 25-tetrol to cholic acid. , 1975, The Journal of clinical investigation.
[22] S. Grundy,et al. Metabolism of β-sitosterol in man , 1970 .
[23] P. Swanson,et al. Cerebrotendinous Xanthomatosis: The Storage of Cholestanol Within the Nervous System , 1968 .
[24] A. Batta,et al. Biosynthesis of Bile Acids in Cerebrotendinous Xanthomatosis , 1985 .
[25] S. Shefer,et al. Determination of hepatic 3-hydroxy-3-methylglutaryl CoA reductase activity in man. , 1974, Journal of lipid research.
[26] S. Grundy,et al. Metabolism of beta-sitosterol in man. , 1970, The Journal of clinical investigation.